- Home
- NBB vs EBS Comparison
NBB vs EBS Comparison
Compare NBB & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBB
- EBS
- Stock Information
- Founded
- NBB 2009
- EBS 1998
- Country
- NBB United States
- EBS United States
- Employees
- NBB N/A
- EBS N/A
- Industry
- NBB Finance Companies
- EBS Biotechnology: Pharmaceutical Preparations
- Sector
- NBB Finance
- EBS Health Care
- Exchange
- NBB Nasdaq
- EBS Nasdaq
- Market Cap
- NBB 462.1M
- EBS 393.9M
- IPO Year
- NBB N/A
- EBS 2006
- Fundamental
- Price
- NBB $15.38
- EBS $5.88
- Analyst Decision
- NBB
- EBS Strong Buy
- Analyst Count
- NBB 0
- EBS 3
- Target Price
- NBB N/A
- EBS $14.33
- AVG Volume (30 Days)
- NBB 73.9K
- EBS 1.2M
- Earning Date
- NBB 01-01-0001
- EBS 05-07-2025
- Dividend Yield
- NBB 8.64%
- EBS N/A
- EPS Growth
- NBB N/A
- EBS N/A
- EPS
- NBB N/A
- EBS N/A
- Revenue
- NBB N/A
- EBS $965,400,000.00
- Revenue This Year
- NBB N/A
- EBS N/A
- Revenue Next Year
- NBB N/A
- EBS $19.88
- P/E Ratio
- NBB N/A
- EBS N/A
- Revenue Growth
- NBB N/A
- EBS N/A
- 52 Week Low
- NBB $13.67
- EBS $4.02
- 52 Week High
- NBB $16.66
- EBS $15.10
- Technical
- Relative Strength Index (RSI)
- NBB 44.94
- EBS 57.55
- Support Level
- NBB $15.01
- EBS $4.71
- Resistance Level
- NBB $15.70
- EBS $6.70
- Average True Range (ATR)
- NBB 0.20
- EBS 0.43
- MACD
- NBB 0.01
- EBS 0.14
- Stochastic Oscillator
- NBB 33.49
- EBS 58.79
About NBB Nuveen Taxable Municipal Income Fund of Beneficial Interest
Nuveen Taxable Municipal Income Fund is a closed-end fund incorporated in the United States. Its primary objective is current income through investments in taxable municipal securities; the secondary objective is to seek enhanced portfolio value and total return. The fund invests primarily in a diversified portfolio of taxable municipal securities.
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. The company operates across three different segments, namely Commercial, Products, and Services. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.